TBPH icon

Theravance Biopharma

98 hedge funds and large institutions have $793M invested in Theravance Biopharma in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 15 closing their positions.

Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
38
Reduced
21
Closed
15
Calls
$2.26M
Puts
$17.3M
Net Calls
-$15M
Net Calls Change
-$1.97M
Name Holding Trade Value Shares
Change
Shares
Change %
PP
101
Paloma Partners
Connecticut
-$229K -10,088 Closed
SG Americas Securities
102
SG Americas Securities
New York
-$156K -6,890 Closed
Marshall Wace
103
Marshall Wace
United Kingdom
-$92K -4,080 Closed
PAM
104
Panagora Asset Management
Massachusetts
-$71K -3,111 Closed
QI
105
QS Investors
New York
-$57K -2,500 Closed
MNBTD
106
Moody National Bank Trust Division
Texas
-$6K -250 Closed
WAM
107
Wealthspire Advisors (Maryland)
Maryland
-$4K -185 Closed
LFA
108
Legacy Financial Advisors
Kentucky
-$2K -94 Closed